Sequent Scientific Ltd (SEQUENT)

Visistha Traders Finance Ltd has combined itself with PI Drugs and Pharmaceuticals Ltd. Confirmation of amalgamation was approved by the High Court on November 12th 2003. As a result, one of the leading companies in the Indian pharmaceutical industry is now under its wing. It is anticipated that the move will benefit both the companies, shareholders and society at large. It will help Visistha Traders further solidify its creative and enterprising portfolio while aiding PI Drugs expand its reach and customer base. The amalgamation will make it easier to access the required resources, human and capital in a more efficient manner. Another positive factor of this step is that it will reduce administrative costs, allowing for a more productive use of resources. Combining the skill sets of both firms also ensures the sector benefits the most efficient and cutting-edge solutions. All in all, this is a step that is expected to lead to a brighter future for the pharmaceutical sector.

Share Price: ₹121.15 per share as on 03 May, 2024 04:01 PM
Market Capitalisation: ₹3,050.57Cr as of today
Revenue: ₹329.36Cr as on December 2023 (Q4 23)
Net Profit: ₹10.68Cr as on December 2023 (Q4 23)
Listing date: 10 Mar, 2016
Chairperson Name: Kamal K Sharma